• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: this medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original PMA or panel track supplement and may not represent the most recent labeling.
 
DeviceLava Liquid Embolic System (Lava LES) and Lava Mixing Kit
Generic NameEmbolization Agent, Vascular
ApplicantSirtex Medical, Inc.
300 Unicorn Park Dr., 2nd Floor ,
Woburn, MA 01801
PMA NumberP220020
Date Received10/06/2022
Decision Date04/04/2023
Product Code QVG 
Docket Number 23M-1377
Notice Date 04/14/2023
Advisory Committee Cardiovascular
Clinical TrialsNCT04649255
Expedited Review Granted? No
Combination ProductNo
Predetermined Change Control Plan AuthorizedNo
Approval Order Statement  
Approval for the Lava Liquid Embolic System (Lava LES) and Lava Mixing Kit. The device is indicated for embolization of arterial hemorrhage in the peripheral vasculature.
Approval OrderApproval Order
SummarySummary of Safety and Effectiveness
LabelingLabeling
Supplements:  S006 S007 S004 S005 S001 S002 S003 S008 
-
-